Veterinary Medicines

Fenoflox 50 mg/ml Solution for Injection for Cattle, Pigs, Dogs and Cats

Authorised
  • Enrofloxacin
Download as PDF

Product identification

Medicine name:
Fenoflox 50 mg/ml Solution for Injection for Cattle, Pigs, Dogs and Cats
Fenoflox 50 mg/ml Solution for Injection for Cattle, Pigs, Dogs and Cats
Active substance:
  • Enrofloxacin
Target species:
  • Pig
  • Cattle
  • Dog
  • Cat
Route of administration:
  • Intramuscular use
  • Intravenous use
  • Subcutaneous use

Product details

Active substance and strength:
  • Enrofloxacin
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        13
        day
  • Intravenous use
    • Cattle
      • Meat and offal
        5
        day
  • Subcutaneous use
    • Cattle
      • Meat and offal
        12
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01MA90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • Container material: Type I Amber GlassContainer closure: Grey teflonised chlorobutyl rubber stopper with an aluminium capContainer colour: AmberContainer volume: 250 mlNo. of containers in a carton: 20 x 250 ml
  • Container material: Type I Amber GlassContainer closure: Grey teflonised chlorobutyl rubber stopper with an aluminium capContainer colour: AmberContainer volume: 250 mlNo. of containers in a carton: 15 x 250 ml
  • Container material: Type I Amber GlassContainer closure: Grey teflonised chlorobutyl rubber stopper with an aluminium capContainer colour: AmberContainer volume: 250 mlNo. of containers in a carton: 12 x 250 ml
  • Container material: Type I Amber GlassContainer closure: Grey teflonised chlorobutyl rubber stopper with an aluminium capContainer colour: AmberContainer volume: 250 mlNo. of containers in a carton: 10 x 250 ml
  • Container material: Type I Amber GlassContainer closure: Grey teflonised chlorobutyl rubber stopper with an aluminium capContainer colour: AmberContainer volume: 250 mlNo. of containers in a carton: 5 x 250 ml
  • Container material: Type I Amber GlassContainer closure: Grey teflonised chlorobutyl rubber stopper with an aluminium capContainer colour: AmberContainer volume: 250 mlNo. of containers in a carton: 1 x 250 ml
  • Container material: Type I Amber GlassContainer closure: Grey teflonised chlorobutyl rubber stopper with an aluminium capContainer colour: AmberContainer volume: 100 mlNo. of containers in a carton: 20 x 100 ml
  • Container material: Type I Amber GlassContainer closure: Grey teflonised chlorobutyl rubber stopper with an aluminium capContainer colour: AmberContainer volume: 100 mlNo. of containers in a carton: 15 x 100 ml
  • Container material: Type I Amber GlassContainer closure: Grey teflonised chlorobutyl rubber stopper with an aluminium capContainer colour: AmberContainer volume: 100 mlNo. of containers in a carton: 12 x 100 ml
  • Container material: Type I Amber GlassContainer closure: Grey teflonised chlorobutyl rubber stopper with an aluminium capContainer colour: AmberContainer volume: 100 mlNo. of containers in a carton: 10 x 100 ml
  • Container material: Type I Amber GlassContainer closure: Grey teflonised chlorobutyl rubber stopper with an aluminium capContainer colour: AmberContainer volume: 100 mlNo. of containers in a carton: 5 x 100 ml
  • Container material: Type I Amber GlassContainer closure: Grey teflonised chlorobutyl rubber stopper with an aluminium capContainer colour: AmberContainer volume: 100 mlNo. of containers in a carton: 1 x 100 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Chanelle Pharmaceuticals Manufacturing Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Labiana Life Sciences S.A.
  • Chanelle Pharmaceuticals Manufacturing Limited
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10987/072/001
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0223/001
Concerned member states:
  • Austria
  • Belgium
  • Cyprus
  • Czechia
  • Finland
  • France
  • Germany
  • Hungary
  • Italy
  • Luxembourg
  • Portugal
  • Slovakia
  • United Kingdom (Northern Ireland)